Page last updated: 2024-10-16

gamma-aminobutyric acid and Aphasia, Primary Progressive

gamma-aminobutyric acid has been researched along with Aphasia, Primary Progressive in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Aphasia, Primary Progressive: A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. (From Brain 1998 Jan;121(Pt 1):115-26)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, AD1
Wang, Z1
Ficek, B1
Webster, K1
Edden, RA1
Tsapkini, K1

Other Studies

1 other study available for gamma-aminobutyric acid and Aphasia, Primary Progressive

ArticleYear
Reductions in GABA following a tDCS-language intervention for primary progressive aphasia.
    Neurobiology of aging, 2019, Volume: 79

    Topics: Aged; Aphasia, Primary Progressive; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Lang

2019